EDITORIAL
Accepted on 17 Jul 2025
Editorial: Antibody-drug Conjugates in Solid and Hematologic Malignancies
doi 10.3389/fimmu.2025.1662653
- 154 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Antibody-drug Conjugates in Solid and Hematologic Malignancies
Antibody-drug Conjugates in Solid and Hematologic Malignancies
2,788
Total downloads
12k
Total views and downloads
Articles
REVIEW
Published on 21 May 2025
Antibody-drug conjugates in cancer therapy: applications and future advances
doi 10.3389/fimmu.2025.1516419
- 3,165 views
SYSTEMATIC REVIEW
Published on 13 May 2025
Antibody-drug conjugates as game changers in bladder cancer: current progress and future directions
doi 10.3389/fimmu.2025.1591191
- 2,173 views
CASE REPORT
Published on 09 Apr 2025
Case Report: Rapid response to gemtuzumab-ozogamicin in a pediatric patient with refractory systemic mastocytosis with AML1::ETO+ acute myeloid leukemia
doi 10.3389/fimmu.2025.1566805
- 945 views
CASE REPORT
Published on 21 Oct 2024
Hepatopulmonary syndrome associated with long-term use of ado-trastuzumab emtansine (T-DM1) for treatment of HER2-positive metastatic breast cancer - a case report and series
doi 10.3389/fonc.2024.1434492
- 1,424 views
CASE REPORT
Published on 16 Sep 2024
Complete response to disitamab vedotin in HER2-low metastatic endometrial carcinoma: a case report and review of the literature
doi 10.3389/fonc.2024.1367140
- 1,335 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore